Gene · 6439
Papers3,679
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,679
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients. | Biomolecules | 2022 | 36551272 | PubTator, text mining | PubMed |
| Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma. | Sci Rep | 2022 | 36543847 | PubTator, text mining | PubMed |
| Significance of thyroid transcription factor 1 and Napsin A for prompting the status of EGFR mutations in lung adenocarcinoma patients. | J Thorac Dis | 2022 | 36524085 | PubTator, text mining | PubMed |
| The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis. | Mol Ther Nucleic Acids | 2022 | 36514354 | PubTator, text mining | PubMed |
| Association between Age at Menarche and Metabolic Syndrome in Southwest Iran: A Population-Based Case-Control Study. | J Res Health Sci | 2022 | 36511376 | PubTator, text mining | PubMed |
| The concentration-dependent effect of hydrocortisone on the structure of model lung surfactant monolayer by using an in silico approach. | RSC Adv | 2022 | 36506480 | PubTator, text mining | PubMed |
| Meconium Aspiration Syndrome in Animal Models: Inflammatory Process, Apoptosis, and Surfactant Inactivation. | Animals (Basel) | 2022 | 36496831 | PubTator, text mining | PubMed |
| Bacterial MazF/MazE toxin-antitoxin suppresses lytic propagation of arbitrium-containing phages. | Cell Rep | 2022 | 36476854 | PubTator, text mining | PubMed |
| An optimized approach and inflation media for obtaining complimentary mass spectrometry-based omics data from human lung tissue. | Front Mol Biosci | 2022 | 36465564 | PubTator, text mining | PubMed |
| Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits. | Front Immunol | 2022 | 36457995 | PubTator, text mining | PubMed |
| Metabolic reprogramming of pulmonary fibrosis. | Front Pharmacol | 2022 | 36452229 | PubTator, text mining | PubMed |
| FGFR2b signalling restricts lineage-flexible alveolar progenitors during mouse lung development and converges in mature alveolar type 2 cells. | Cell Mol Life Sci | 2022 | 36445537 | PubTator, text mining | PubMed |
| Single-cell transcriptomic characterization reveals the landscape of airway remodeling and inflammation in a cynomolgus monkey model of asthma. | Front Immunol | 2022 | 36439114 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study. | Ther Adv Med Oncol | 2022 | 36419724 | PubTator, text mining | PubMed |
| MSCs vs. iPSCs: Potential in therapeutic applications. | Front Cell Dev Biol | 2022 | 36407112 | PubTator, text mining | PubMed |
| Personalized medicine using omics approaches in acute respiratory distress syndrome to identify biological phenotypes. | Respir Res | 2022 | 36403043 | PubTator, text mining | PubMed |
| Molecular recognition of a membrane-anchored HIV-1 pan-neutralizing epitope. | Commun Biol | 2022 | 36400835 | PubTator, text mining | PubMed |
| Spontaneous bacterial peritonitis in hepatocellular carcinoma after PD-1 inhibitor therapy: two clinical cases. | Heliyon | 2022 | 36387537 | PubTator, text mining | PubMed |
| The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-Therapeutic potential exploration in lung injury. | Acta Pharm Sin B | 2022 | 36386481 | PubTator, text mining | PubMed |
| Less Invasive Surfactant Administration: A Review of Current Evidence of Clinical Outcomes With Beractant. | Cureus | 2022 | 36381708 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6439/papers?page=25